

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 8.35665094 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.11979783 |
| 3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.50258600 |
| 4 | negative thymic T cell selection (GO:0045060) | 6.15148099 |
| 5 | negative T cell selection (GO:0043383) | 6.02128506 |
| 6 | positive thymic T cell selection (GO:0045059) | 5.91623926 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 5.89906437 |
| 8 | response to interleukin-15 (GO:0070672) | 5.23928496 |
| 9 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.00045812 |
| 10 | positive T cell selection (GO:0043368) | 4.99904033 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.94120076 |
| 12 | thymic T cell selection (GO:0045061) | 4.93524894 |
| 13 | NIK/NF-kappaB signaling (GO:0038061) | 4.87361519 |
| 14 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.78532610 |
| 15 | B cell homeostasis (GO:0001782) | 4.73833171 |
| 16 | positive regulation of isotype switching (GO:0045830) | 4.71082521 |
| 17 | T cell selection (GO:0045058) | 4.65183871 |
| 18 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.64019056 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 4.48301479 |
| 20 | regulation of regulatory T cell differentiation (GO:0045589) | 4.45004693 |
| 21 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.44219562 |
| 22 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.38552928 |
| 23 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.35674818 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.35249790 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.35249790 |
| 26 | positive regulation of humoral immune response (GO:0002922) | 4.32520515 |
| 27 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 4.29527989 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.22679323 |
| 29 | regulation of immunoglobulin secretion (GO:0051023) | 4.19578062 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 4.14107856 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 4.14107856 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.14107856 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.14107856 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.14107856 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 4.14107856 |
| 36 | tolerance induction (GO:0002507) | 4.12933766 |
| 37 | * positive regulation of interleukin-2 production (GO:0032743) | 4.09267815 |
| 38 | * CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.08415679 |
| 39 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.04765949 |
| 40 | activated T cell proliferation (GO:0050798) | 4.03896499 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 3.98027219 |
| 42 | cellular response to nicotine (GO:0071316) | 3.96079715 |
| 43 | positive regulation of DNA recombination (GO:0045911) | 3.96032278 |
| 44 | positive regulation of T cell cytokine production (GO:0002726) | 3.95642213 |
| 45 | positive regulation of B cell mediated immunity (GO:0002714) | 3.94993900 |
| 46 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.94993900 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.94696029 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.91430108 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.91430108 |
| 50 | * regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.89768153 |
| 51 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.88725567 |
| 52 | * type I interferon signaling pathway (GO:0060337) | 3.87419098 |
| 53 | * cellular response to type I interferon (GO:0071357) | 3.87419098 |
| 54 | * response to type I interferon (GO:0034340) | 3.86864973 |
| 55 | regulation of vitamin metabolic process (GO:0030656) | 3.86678755 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 3.85856986 |
| 57 | cytidine deamination (GO:0009972) | 3.85076527 |
| 58 | cytidine metabolic process (GO:0046087) | 3.85076527 |
| 59 | cytidine catabolic process (GO:0006216) | 3.85076527 |
| 60 | positive regulation of immunoglobulin production (GO:0002639) | 3.65142809 |
| 61 | T cell costimulation (GO:0031295) | 3.64797796 |
| 62 | B cell mediated immunity (GO:0019724) | 3.63924513 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.63308190 |
| 64 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.62351713 |
| 65 | B cell proliferation (GO:0042100) | 3.62124942 |
| 66 | leukocyte aggregation (GO:0070486) | 3.58029479 |
| 67 | lymphocyte costimulation (GO:0031294) | 3.57502727 |
| 68 | T cell receptor signaling pathway (GO:0050852) | 3.55356170 |
| 69 | regulation of isotype switching (GO:0045191) | 3.55013038 |
| 70 | positive regulation of interferon-alpha production (GO:0032727) | 3.53946173 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.53252253 |
| 72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.52520463 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50675423 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 3.50187953 |
| 75 | regulation of T cell tolerance induction (GO:0002664) | 3.48904078 |
| 76 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.45628227 |
| 77 | positive regulation of activated T cell proliferation (GO:0042104) | 3.45183314 |
| 78 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.44197402 |
| 79 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.44197402 |
| 80 | negative regulation of B cell proliferation (GO:0030889) | 3.40503851 |
| 81 | regulation of immunoglobulin production (GO:0002637) | 3.40296105 |
| 82 | response to muramyl dipeptide (GO:0032495) | 3.39647167 |
| 83 | regulation of interferon-alpha production (GO:0032647) | 3.38712312 |
| 84 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.38261506 |
| 85 | T cell proliferation (GO:0042098) | 3.36866679 |
| 86 | mature B cell differentiation (GO:0002335) | 3.33368711 |
| 87 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.32809111 |
| 88 | Peyers patch development (GO:0048541) | 3.32809111 |
| 89 | * myeloid dendritic cell differentiation (GO:0043011) | 3.32418252 |
| 90 | interferon-gamma production (GO:0032609) | 3.31389617 |
| 91 | T cell homeostasis (GO:0043029) | 3.29262237 |
| 92 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.26906357 |
| 93 | nuclear pore complex assembly (GO:0051292) | 3.25780017 |
| 94 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.23030717 |
| 95 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.22909502 |
| 96 | activation of MAPKKK activity (GO:0000185) | 3.22500474 |
| 97 | natural killer cell differentiation (GO:0001779) | 3.22270591 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 3.22129570 |
| 99 | * regulation of interleukin-2 production (GO:0032663) | 3.21368797 |
| 100 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.18722651 |
| 101 | regulation of B cell mediated immunity (GO:0002712) | 3.18109009 |
| 102 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.16668210 |
| 103 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.16668210 |
| 104 | detection of bacterium (GO:0016045) | 3.16112375 |
| 105 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.15926180 |
| 106 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.14058728 |
| 107 | regulation of thymocyte apoptotic process (GO:0070243) | 3.13942637 |
| 108 | * T cell lineage commitment (GO:0002360) | 3.12600211 |
| 109 | T cell migration (GO:0072678) | 3.12582085 |
| 110 | positive regulation of macrophage cytokine production (GO:0060907) | 3.10873576 |
| 111 | regulation of interleukin-12 production (GO:0032655) | 3.09513837 |
| 112 | T-helper 1 type immune response (GO:0042088) | 3.07581716 |
| 113 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.06691674 |
| 114 | positive regulation of B cell activation (GO:0050871) | 3.05147560 |
| 115 | B cell receptor signaling pathway (GO:0050853) | 3.04774990 |
| 116 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04439422 |
| 117 | * myeloid dendritic cell activation (GO:0001773) | 3.04067530 |
| 118 | regulation of B cell activation (GO:0050864) | 3.03283510 |
| 119 | positive regulation of T cell differentiation (GO:0045582) | 3.02187067 |
| 120 | * cellular response to interferon-gamma (GO:0071346) | 3.00393916 |
| 121 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99586912 |
| 122 | response to host immune response (GO:0052572) | 2.99586912 |
| 123 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.99490999 |
| 124 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.99278638 |
| 125 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.98608022 |
| 126 | negative regulation of T cell mediated immunity (GO:0002710) | 2.98590876 |
| 127 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.95790947 |
| 128 | negative regulation of B cell apoptotic process (GO:0002903) | 2.94137322 |
| 129 | positive regulation of protein homooligomerization (GO:0032464) | 2.93885801 |
| 130 | regulation of B cell proliferation (GO:0030888) | 2.92180657 |
| 131 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.89508589 |
| 132 | T cell apoptotic process (GO:0070231) | 2.86859703 |
| 133 | positive regulation of B cell proliferation (GO:0030890) | 2.86679188 |
| 134 | positive regulation of lymphocyte differentiation (GO:0045621) | 2.84875874 |
| 135 | growth hormone receptor signaling pathway (GO:0060396) | 2.84742135 |
| 136 | positive regulation of T cell proliferation (GO:0042102) | 2.84577432 |
| 137 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.84388287 |
| 138 | regulation of response to interferon-gamma (GO:0060330) | 2.84056027 |
| 139 | leukocyte homeostasis (GO:0001776) | 2.82529165 |
| 140 | detection of other organism (GO:0098543) | 2.82323594 |
| 141 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81993860 |
| 142 | germinal center formation (GO:0002467) | 2.81404429 |
| 143 | lymphocyte homeostasis (GO:0002260) | 2.81294414 |
| 144 | lymphocyte migration (GO:0072676) | 2.80445503 |
| 145 | positive regulation of interleukin-12 production (GO:0032735) | 2.80437792 |
| 146 | positive regulation of protein oligomerization (GO:0032461) | 2.79237659 |
| 147 | response to host (GO:0075136) | 2.78674948 |
| 148 | response to host defenses (GO:0052200) | 2.78674948 |
| 149 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.78674948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.60332228 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.33072732 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.65792956 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.43658043 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.86325241 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.76790102 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.46150446 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.23574740 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.23542336 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.20597455 |
| 11 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.18845211 |
| 12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.08509918 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.98578378 |
| 14 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.81078634 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.77111462 |
| 16 | * MAF_26560356_Chip-Seq_TH1_Human | 2.66206003 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63069159 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55516784 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50498925 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.50206039 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31628730 |
| 22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.31441016 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.23930396 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21574019 |
| 25 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19517577 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11846009 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99572327 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98622171 |
| 29 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.96210389 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94204254 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.93783319 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92306997 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90512461 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88054304 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.87973771 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87537642 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84120825 |
| 38 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81712804 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78461527 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.78324550 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.72998471 |
| 42 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70465327 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66202185 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.65320373 |
| 45 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.63008627 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60363222 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59514311 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58227635 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54763872 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53044990 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49470130 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42540522 |
| 53 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42002608 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40561032 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40391612 |
| 56 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32021583 |
| 57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.26998991 |
| 58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24816733 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.24776905 |
| 60 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.24208682 |
| 61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23667023 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19751481 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17213616 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16928324 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16340381 |
| 66 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13260602 |
| 67 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11796246 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11677203 |
| 69 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.11183702 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10983265 |
| 71 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10833810 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10761622 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08336122 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07733796 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06623665 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06063128 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06002808 |
| 78 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03903138 |
| 79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.02859911 |
| 80 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.01269550 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00826563 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98102293 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97854234 |
| 84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97692734 |
| 85 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97381422 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97008646 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.95841570 |
| 88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95696742 |
| 89 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94774670 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94100127 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93709900 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93267775 |
| 93 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92807673 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91771655 |
| 95 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.90464247 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90392912 |
| 97 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89825403 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89492526 |
| 99 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.88455168 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87600241 |
| 101 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86778679 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86135364 |
| 103 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85559075 |
| 104 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85061328 |
| 105 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84551605 |
| 106 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84330539 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82808721 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.82735193 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82288526 |
| 110 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81749696 |
| 111 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.81526933 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78925190 |
| 113 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.78894149 |
| 114 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.78825895 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78439957 |
| 116 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.76657129 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75626542 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75568335 |
| 119 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75519855 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.72441641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.37625832 |
| 2 | MP0003303_peritoneal_inflammation | 4.34550971 |
| 3 | MP0003436_decreased_susceptibility_to | 3.83088285 |
| 4 | MP0000685_abnormal_immune_system | 3.76114615 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.60033202 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.39343561 |
| 7 | * MP0001800_abnormal_humoral_immune | 3.36831146 |
| 8 | MP0005671_abnormal_response_to | 3.32181237 |
| 9 | * MP0001790_abnormal_immune_system | 3.22666024 |
| 10 | * MP0005387_immune_system_phenotype | 3.22666024 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.07040388 |
| 12 | MP0004510_myositis | 2.99067640 |
| 13 | MP0003866_abnormal_defecation | 2.78798703 |
| 14 | MP0002405_respiratory_system_inflammati | 2.73289767 |
| 15 | * MP0002723_abnormal_immune_serum | 2.67094806 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.65378656 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.61518500 |
| 18 | * MP0002398_abnormal_bone_marrow | 2.57429321 |
| 19 | MP0001853_heart_inflammation | 2.53151283 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.45864079 |
| 21 | * MP0001819_abnormal_immune_cell | 2.41128389 |
| 22 | MP0009785_altered_susceptibility_to | 2.39667773 |
| 23 | MP0001873_stomach_inflammation | 2.37457660 |
| 24 | MP0008057_abnormal_DNA_replication | 2.34801271 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.30075949 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.29929020 |
| 27 | MP0000703_abnormal_thymus_morphology | 2.26692741 |
| 28 | * MP0000716_abnormal_immune_system | 2.20987347 |
| 29 | * MP0000689_abnormal_spleen_morphology | 2.11848952 |
| 30 | * MP0005025_abnormal_response_to | 2.08407856 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 2.04505448 |
| 32 | * MP0002722_abnormal_immune_system | 1.99127486 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.99044512 |
| 34 | MP0002163_abnormal_gland_morphology | 1.94916506 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.91105485 |
| 36 | MP0002933_joint_inflammation | 1.82691371 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.82538334 |
| 38 | * MP0002429_abnormal_blood_cell | 1.81871507 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.81281866 |
| 40 | MP0003724_increased_susceptibility_to | 1.73382963 |
| 41 | MP0002419_abnormal_innate_immunity | 1.68850588 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.62567048 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.61744126 |
| 44 | MP0004947_skin_inflammation | 1.59455002 |
| 45 | MP0004381_abnormal_hair_follicle | 1.57402942 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.53376978 |
| 47 | MP0006082_CNS_inflammation | 1.49640559 |
| 48 | MP0005310_abnormal_salivary_gland | 1.49126262 |
| 49 | MP0005451_abnormal_body_composition | 1.46767704 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.46121998 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.43213779 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.36409944 |
| 53 | * MP0002166_altered_tumor_susceptibility | 1.27661652 |
| 54 | MP0000604_amyloidosis | 1.17836231 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.11124685 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.08120557 |
| 57 | MP0000371_diluted_coat_color | 1.07813546 |
| 58 | MP0003045_fibrosis | 1.07783693 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.06839177 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.04591274 |
| 61 | MP0000490_abnormal_crypts_of | 1.04474438 |
| 62 | MP0010307_abnormal_tumor_latency | 1.04448213 |
| 63 | MP0002019_abnormal_tumor_incidence | 1.02424553 |
| 64 | * MP0002006_tumorigenesis | 1.01887842 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.96702835 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.96702835 |
| 67 | MP0002254_reproductive_system_inflammat | 0.94315133 |
| 68 | MP0001348_abnormal_lacrimal_gland | 0.94064802 |
| 69 | MP0003448_altered_tumor_morphology | 0.91167003 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.89199334 |
| 71 | MP0008469_abnormal_protein_level | 0.88878408 |
| 72 | MP0005623_abnormal_meninges_morphology | 0.88120530 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 0.87821349 |
| 74 | MP0001851_eye_inflammation | 0.87052994 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.84896974 |
| 76 | MP0001663_abnormal_digestive_system | 0.84888318 |
| 77 | MP0003077_abnormal_cell_cycle | 0.84471650 |
| 78 | MP0001881_abnormal_mammary_gland | 0.81552077 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.81529269 |
| 80 | MP0001346_abnormal_lacrimal_gland | 0.81411172 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.79241753 |
| 82 | MP0009278_abnormal_bone_marrow | 0.75250302 |
| 83 | MP0000350_abnormal_cell_proliferation | 0.75038209 |
| 84 | MP0000609_abnormal_liver_physiology | 0.68998164 |
| 85 | MP0000858_altered_metastatic_potential | 0.68360790 |
| 86 | MP0003795_abnormal_bone_structure | 0.67057321 |
| 87 | MP0002928_abnormal_bile_duct | 0.66291085 |
| 88 | MP0003091_abnormal_cell_migration | 0.65913791 |
| 89 | MP0010094_abnormal_chromosome_stability | 0.63972687 |
| 90 | MP0008058_abnormal_DNA_repair | 0.63618854 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.63350609 |
| 92 | MP0000313_abnormal_cell_death | 0.61614816 |
| 93 | MP0004957_abnormal_blastocyst_morpholog | 0.61599590 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60633573 |
| 95 | MP0005390_skeleton_phenotype | 0.58294661 |
| 96 | MP0000627_abnormal_mammary_gland | 0.57686589 |
| 97 | MP0002009_preneoplasia | 0.57589956 |
| 98 | MP0004742_abnormal_vestibular_system | 0.57198363 |
| 99 | MP0005621_abnormal_cell_physiology | 0.56526285 |
| 100 | MP0009764_decreased_sensitivity_to | 0.56187333 |
| 101 | MP0009115_abnormal_fat_cell | 0.55321418 |
| 102 | MP0003868_abnormal_feces_composition | 0.55182955 |
| 103 | MP0002095_abnormal_skin_pigmentation | 0.55027388 |
| 104 | MP0003252_abnormal_bile_duct | 0.51974188 |
| 105 | MP0008872_abnormal_physiological_respon | 0.51743302 |
| 106 | MP0001216_abnormal_epidermal_layer | 0.51416417 |
| 107 | MP0002088_abnormal_embryonic_growth/wei | 0.50453777 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.48716632 |
| 109 | MP0003984_embryonic_growth_retardation | 0.48689601 |
| 110 | MP0008007_abnormal_cellular_replicative | 0.48529713 |
| 111 | MP0008874_decreased_physiological_sensi | 0.48414049 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.48208468 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.48119598 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.47380677 |
| 115 | MP0005166_decreased_susceptibility_to | 0.47368145 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.47343110 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.46056568 |
| 118 | MP0005023_abnormal_wound_healing | 0.45890464 |
| 119 | MP0003111_abnormal_nucleus_morphology | 0.45155385 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.45116050 |
| 121 | MP0000249_abnormal_blood_vessel | 0.44073394 |
| 122 | MP0009763_increased_sensitivity_to | 0.43951511 |
| 123 | MP0000367_abnormal_coat/_hair | 0.43271177 |
| 124 | MP0000733_abnormal_muscle_development | 0.42417628 |
| 125 | MP0000598_abnormal_liver_morphology | 0.42282071 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.42173710 |
| 127 | MP0001915_intracranial_hemorrhage | 0.41305172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Panhypogammaglobulinemia (HP:0003139) | 5.65299249 |
| 2 | T lymphocytopenia (HP:0005403) | 5.57940021 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.49527208 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.44029535 |
| 5 | Stomatitis (HP:0010280) | 5.39757096 |
| 6 | Recurrent fungal infections (HP:0002841) | 5.31916778 |
| 7 | Recurrent viral infections (HP:0004429) | 5.07907842 |
| 8 | Severe combined immunodeficiency (HP:0004430) | 4.87177706 |
| 9 | Abnormality of B cell number (HP:0010975) | 4.71108543 |
| 10 | B lymphocytopenia (HP:0010976) | 4.71108543 |
| 11 | Abnormality of T cells (HP:0002843) | 4.30900385 |
| 12 | Chronic diarrhea (HP:0002028) | 4.24300579 |
| 13 | Combined immunodeficiency (HP:0005387) | 4.24092915 |
| 14 | Recurrent bronchitis (HP:0002837) | 4.14068319 |
| 15 | IgA deficiency (HP:0002720) | 4.00648741 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 4.00230696 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.91823008 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.91823008 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.79925176 |
| 20 | Thrombocytosis (HP:0001894) | 3.79574688 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.78827759 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.77810475 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.66174573 |
| 24 | Increased density of long bones (HP:0006392) | 3.53849297 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.53075228 |
| 26 | Fatigue (HP:0012378) | 3.52725074 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.51059943 |
| 28 | IgG deficiency (HP:0004315) | 3.49439183 |
| 29 | IgM deficiency (HP:0002850) | 3.43769882 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 3.39803804 |
| 31 | Recurrent lower respiratory tract infections (HP:0002783) | 3.35342910 |
| 32 | Abnormality of the fingertips (HP:0001211) | 3.33319575 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.25173293 |
| 34 | Verrucae (HP:0200043) | 3.23620624 |
| 35 | Papilloma (HP:0012740) | 3.23620624 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.22584964 |
| 37 | Gastrointestinal stroma tumor (HP:0100723) | 3.20795230 |
| 38 | Persistence of primary teeth (HP:0006335) | 3.07179719 |
| 39 | Myocardial infarction (HP:0001658) | 3.05608012 |
| 40 | Arterial thrombosis (HP:0004420) | 3.03555101 |
| 41 | Vasculitis (HP:0002633) | 3.02682766 |
| 42 | Encephalitis (HP:0002383) | 3.01270620 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.92202836 |
| 44 | Meningitis (HP:0001287) | 2.88855718 |
| 45 | Chest pain (HP:0100749) | 2.88788893 |
| 46 | Chronic otitis media (HP:0000389) | 2.87965538 |
| 47 | Cellulitis (HP:0100658) | 2.87802614 |
| 48 | Lymphopenia (HP:0001888) | 2.84658354 |
| 49 | Viral hepatitis (HP:0006562) | 2.84547844 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84103416 |
| 51 | Nasal polyposis (HP:0100582) | 2.79299389 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.78667943 |
| 53 | Lymphoma (HP:0002665) | 2.72488693 |
| 54 | Thyroiditis (HP:0100646) | 2.71710081 |
| 55 | Increased IgM level (HP:0003496) | 2.70388185 |
| 56 | Colitis (HP:0002583) | 2.67827109 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.65995858 |
| 58 | Amaurosis fugax (HP:0100576) | 2.62409248 |
| 59 | Eosinophilia (HP:0001880) | 2.61019479 |
| 60 | Squamous cell carcinoma (HP:0002860) | 2.60807627 |
| 61 | Leukocytosis (HP:0001974) | 2.58927679 |
| 62 | Joint swelling (HP:0001386) | 2.49529194 |
| 63 | Increased IgE level (HP:0003212) | 2.48054438 |
| 64 | Xerostomia (HP:0000217) | 2.46271937 |
| 65 | Emphysema (HP:0002097) | 2.43762822 |
| 66 | Acute myeloid leukemia (HP:0004808) | 2.40671975 |
| 67 | Myositis (HP:0100614) | 2.39389726 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.39383475 |
| 69 | Recurrent skin infections (HP:0001581) | 2.38633297 |
| 70 | Hypertensive crisis (HP:0100735) | 2.37033972 |
| 71 | Pustule (HP:0200039) | 2.34912980 |
| 72 | Hemoptysis (HP:0002105) | 2.32744291 |
| 73 | Urticaria (HP:0001025) | 2.31761474 |
| 74 | Impaired proprioception (HP:0010831) | 2.31106253 |
| 75 | Acute hepatic failure (HP:0006554) | 2.29495692 |
| 76 | Skin rash (HP:0000988) | 2.28003853 |
| 77 | Bronchitis (HP:0012387) | 2.23922020 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.23793216 |
| 79 | Recurrent otitis media (HP:0000403) | 2.22343246 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.20865547 |
| 81 | Optic neuritis (HP:0100653) | 2.20865547 |
| 82 | Granulocytopenia (HP:0001913) | 2.20322848 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.20086694 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.17803551 |
| 85 | Osteomyelitis (HP:0002754) | 2.17630856 |
| 86 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16389228 |
| 87 | Obstructive lung disease (HP:0006536) | 2.16389228 |
| 88 | Basal cell carcinoma (HP:0002671) | 2.13253900 |
| 89 | Polycythemia (HP:0001901) | 2.13111662 |
| 90 | Bronchiectasis (HP:0002110) | 2.06817879 |
| 91 | Abnormality of male internal genitalia (HP:0000022) | 2.05921428 |
| 92 | Chronic sinusitis (HP:0011109) | 2.05419184 |
| 93 | Abnormal pancreas size (HP:0012094) | 2.02830432 |
| 94 | Gingival bleeding (HP:0000225) | 2.02100019 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 2.01931366 |
| 96 | Recurrent abscess formation (HP:0002722) | 2.01030063 |
| 97 | Neutropenia (HP:0001875) | 2.01005632 |
| 98 | Pulmonary fibrosis (HP:0002206) | 1.99868301 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 1.99834883 |
| 100 | Abnormality of macrophages (HP:0004311) | 1.98790570 |
| 101 | Spontaneous hematomas (HP:0007420) | 1.97305684 |
| 102 | Restrictive lung disease (HP:0002091) | 1.97230070 |
| 103 | Periodontitis (HP:0000704) | 1.97036786 |
| 104 | Peritonitis (HP:0002586) | 1.96453142 |
| 105 | Sepsis (HP:0100806) | 1.96266666 |
| 106 | Abnormality of the peritoneum (HP:0002585) | 1.92602562 |
| 107 | Cheilitis (HP:0100825) | 1.92416364 |
| 108 | Cutis marmorata (HP:0000965) | 1.91713462 |
| 109 | Gangrene (HP:0100758) | 1.91100719 |
| 110 | Villous atrophy (HP:0011473) | 1.90841514 |
| 111 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.90841514 |
| 112 | Peripheral hypomyelination (HP:0007182) | 1.90212770 |
| 113 | Leukopenia (HP:0001882) | 1.89199104 |
| 114 | Acrocyanosis (HP:0001063) | 1.89142302 |
| 115 | Recurrent bacterial skin infections (HP:0005406) | 1.87518786 |
| 116 | Orchitis (HP:0100796) | 1.85226436 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.84238948 |
| 118 | Arthralgia (HP:0002829) | 1.84014387 |
| 119 | Hepatitis (HP:0012115) | 1.82977466 |
| 120 | Keratoconjunctivitis (HP:0001096) | 1.82918271 |
| 121 | Skin ulcer (HP:0200042) | 1.82912702 |
| 122 | Poikiloderma (HP:0001029) | 1.81213780 |
| 123 | Carpal bone hypoplasia (HP:0001498) | 1.80162570 |
| 124 | Interstitial pulmonary disease (HP:0006530) | 1.78201313 |
| 125 | * Somatic mutation (HP:0001428) | 1.77371730 |
| 126 | Esophageal varix (HP:0002040) | 1.76831626 |
| 127 | Gingivitis (HP:0000230) | 1.74135063 |
| 128 | Entropion (HP:0000621) | 1.73095040 |
| 129 | Dysmetric saccades (HP:0000641) | 1.71847107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.48505624 |
| 2 | PRPF4B | 4.80753080 |
| 3 | TXK | 4.04134916 |
| 4 | JAK3 | 3.76698194 |
| 5 | MAP3K14 | 3.48621844 |
| 6 | ZAP70 | 3.14682441 |
| 7 | SMG1 | 3.01253010 |
| 8 | MAP3K10 | 2.70416724 |
| 9 | EEF2K | 2.66891905 |
| 10 | IKBKB | 2.47156073 |
| 11 | CHUK | 2.44622585 |
| 12 | CDK12 | 2.41482730 |
| 13 | PIM2 | 2.17242376 |
| 14 | NEK9 | 2.13078901 |
| 15 | ITK | 2.07484055 |
| 16 | TAOK1 | 1.87406499 |
| 17 | TYK2 | 1.82125424 |
| 18 | FGFR4 | 1.74034697 |
| 19 | GRK6 | 1.66559238 |
| 20 | TSSK6 | 1.65092438 |
| 21 | TRIB3 | 1.64718845 |
| 22 | MAP3K11 | 1.64140592 |
| 23 | TAF1 | 1.58245035 |
| 24 | TEC | 1.57453584 |
| 25 | FGFR3 | 1.51655987 |
| 26 | MAP2K3 | 1.49940639 |
| 27 | SYK | 1.49633638 |
| 28 | STK10 | 1.49517013 |
| 29 | BMPR2 | 1.47777855 |
| 30 | EPHB1 | 1.45156202 |
| 31 | IKBKE | 1.44480538 |
| 32 | MAP3K7 | 1.43811511 |
| 33 | LCK | 1.43624128 |
| 34 | STK24 | 1.43102225 |
| 35 | EPHA3 | 1.42106642 |
| 36 | HCK | 1.41562863 |
| 37 | BTK | 1.40753088 |
| 38 | PIM1 | 1.39542348 |
| 39 | TBK1 | 1.37607527 |
| 40 | NLK | 1.36914780 |
| 41 | TAOK2 | 1.33112774 |
| 42 | TAOK3 | 1.29941115 |
| 43 | CSK | 1.29070159 |
| 44 | MAPK11 | 1.26176230 |
| 45 | ALK | 1.21311549 |
| 46 | RPS6KA4 | 1.21283613 |
| 47 | JAK1 | 1.19318510 |
| 48 | MAP3K3 | 1.12959548 |
| 49 | CCNB1 | 1.08386672 |
| 50 | BRD4 | 1.05764151 |
| 51 | MAP3K13 | 1.04866638 |
| 52 | LRRK2 | 1.01735764 |
| 53 | SIK2 | 0.96718284 |
| 54 | JAK2 | 0.92829091 |
| 55 | ERN1 | 0.88936467 |
| 56 | RAF1 | 0.88180525 |
| 57 | BLK | 0.85823447 |
| 58 | RPS6KA5 | 0.81879958 |
| 59 | PRKCQ | 0.80513233 |
| 60 | LYN | 0.80478376 |
| 61 | CDC7 | 0.79053634 |
| 62 | PASK | 0.78791192 |
| 63 | NME1 | 0.78342805 |
| 64 | MATK | 0.74708777 |
| 65 | RIPK4 | 0.74064391 |
| 66 | CDK4 | 0.73473160 |
| 67 | NME2 | 0.72899664 |
| 68 | MAP3K8 | 0.71114079 |
| 69 | PRKCI | 0.69539136 |
| 70 | CDK9 | 0.69168877 |
| 71 | FES | 0.68355297 |
| 72 | MAPK7 | 0.66643096 |
| 73 | CDC42BPA | 0.66328950 |
| 74 | CSF1R | 0.66090711 |
| 75 | MST4 | 0.64570392 |
| 76 | MAPK12 | 0.62185749 |
| 77 | PRKCH | 0.61720849 |
| 78 | PKN2 | 0.59573733 |
| 79 | BUB1 | 0.59250187 |
| 80 | CHEK1 | 0.58784727 |
| 81 | IRAK4 | 0.58442698 |
| 82 | RPS6KA1 | 0.58230935 |
| 83 | MAP3K1 | 0.57714506 |
| 84 | KIT | 0.56504298 |
| 85 | SIK3 | 0.56473255 |
| 86 | MAPK4 | 0.56441158 |
| 87 | RPS6KB2 | 0.55834758 |
| 88 | MTOR | 0.54056565 |
| 89 | PDGFRB | 0.54032567 |
| 90 | SIK1 | 0.53248955 |
| 91 | TGFBR1 | 0.52770476 |
| 92 | MAP3K5 | 0.52647269 |
| 93 | EIF2AK2 | 0.52082236 |
| 94 | MAP3K9 | 0.51721490 |
| 95 | PTK6 | 0.51589313 |
| 96 | HIPK2 | 0.51574771 |
| 97 | MELK | 0.50331795 |
| 98 | MAPKAPK2 | 0.50181948 |
| 99 | MAPKAPK5 | 0.49933897 |
| 100 | FGFR1 | 0.49472344 |
| 101 | PAK2 | 0.49223045 |
| 102 | CLK1 | 0.47853666 |
| 103 | CDK6 | 0.47307291 |
| 104 | EGFR | 0.46928598 |
| 105 | CAMK1G | 0.46283777 |
| 106 | RPS6KB1 | 0.45356396 |
| 107 | MARK3 | 0.45334464 |
| 108 | INSR | 0.42221934 |
| 109 | MARK2 | 0.41013041 |
| 110 | VRK2 | 0.40286544 |
| 111 | SCYL2 | 0.38527240 |
| 112 | FGR | 0.38459801 |
| 113 | MKNK2 | 0.37003130 |
| 114 | ABL1 | 0.36747387 |
| 115 | IRAK2 | 0.36343624 |
| 116 | CSNK1D | 0.34920114 |
| 117 | ATR | 0.34860319 |
| 118 | MKNK1 | 0.34138773 |
| 119 | IRAK1 | 0.33816573 |
| 120 | STK4 | 0.33349237 |
| 121 | EIF2AK3 | 0.33098458 |
| 122 | CDK19 | 0.32646436 |
| 123 | PDK1 | 0.32454309 |
| 124 | NEK1 | 0.32261410 |
| 125 | CDK7 | 0.32154445 |
| 126 | GSK3A | 0.31327207 |
| 127 | SGK3 | 0.29853863 |
| 128 | TGFBR2 | 0.29143407 |
| 129 | IRAK3 | 0.29054600 |
| 130 | YES1 | 0.28199950 |
| 131 | TLK1 | 0.27183244 |
| 132 | TRPM7 | 0.25053655 |
| 133 | DAPK3 | 0.24621330 |
| 134 | CAMKK1 | 0.23761558 |
| 135 | MAPK3 | 0.23010427 |
| 136 | NTRK2 | 0.22048421 |
| 137 | VRK1 | 0.20462081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.92035351 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.33476526 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.20342837 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.20086059 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.17837504 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.49671364 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.46564945 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43790802 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40866867 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.32665644 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.29457802 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09992767 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09280555 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.98412043 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.95723576 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.84292317 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78080461 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72698762 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72262004 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.66888263 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66732064 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66500481 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62375841 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59330709 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.53163442 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52036843 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50777923 |
| 28 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.49822480 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.45010354 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44483885 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42131022 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38956225 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38697822 |
| 34 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.30288312 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.27682196 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 1.26430602 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.22972942 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22470272 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19784780 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.19731386 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19282373 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17110747 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.10913371 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10355917 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.08803424 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.08649651 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05830065 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99876920 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95961518 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95569018 |
| 51 | DNA replication_Homo sapiens_hsa03030 | 0.92865537 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91208494 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87720271 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.87482510 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.87021789 |
| 56 | Spliceosome_Homo sapiens_hsa03040 | 0.85812585 |
| 57 | RNA transport_Homo sapiens_hsa03013 | 0.84681171 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84243924 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.81218484 |
| 60 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78213548 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72709210 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72266967 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.65331290 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64163287 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.60918778 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.60431815 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58587338 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57617923 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57026905 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56197643 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.54690029 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.53705563 |
| 73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51974522 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49955836 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49763273 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49527025 |
| 77 | Mismatch repair_Homo sapiens_hsa03430 | 0.49032927 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47115651 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.46235339 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.45706353 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45621105 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40721044 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38432668 |
| 84 | Base excision repair_Homo sapiens_hsa03410 | 0.38299108 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.37900979 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37748978 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37705611 |
| 88 | Proteasome_Homo sapiens_hsa03050 | 0.37029085 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36378844 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35623370 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35156314 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34694074 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.34603945 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.34241798 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31838742 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30788849 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30053966 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28799543 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26276157 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26119156 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.25777502 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25730362 |
| 103 | Ribosome_Homo sapiens_hsa03010 | 0.25574124 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25154816 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23590695 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23299991 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.22980126 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22310180 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22165383 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21756021 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.20802594 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19371932 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19006315 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17641309 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.15036235 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.09145980 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08160771 |

